Search Results - "Sinclair, Rodney"

Sublingual minoxidil increases fibre diameter in male androgenetic alopecia: a proxy for reversal of hair follicle miniaturization.

Authors: Sinclair, Rodney Sicinska, Justyna Bokhari, Laita et al.

Source: Clinical & Experimental Dermatology. Jul2025, Vol. 50 Issue 7, p1362-1365. 4p.

Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia.

Authors: Sinclair, Rodney Eisman, Samantha Lee, Carol M. Y. et al.

Source: Australasian Journal of Dermatology. Jun2025, Vol. 66 Issue 4, pe235-e240. 6p.

Alopecia Areata Prevalence in Australia: Insights From a Nationally Representative Cross‐Sectional Survey Study.

Authors: Sinclair, Rodney Eisman, Samantha Yip, Leona et al.

Source: Australasian Journal of Dermatology. May2026, p1. 10p. 4 Illustrations.

Australian dermatologists' prescribing behaviours for female androgenetic alopecia.

Authors: Willems, Anneliese Sinclair, Rodney

Source: Australasian Journal of Dermatology. Feb2025, Vol. 66 Issue 1, pe20-e23. 4p.

Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations.

Authors: Sinclair, Rodney Yang, Chao‐Chun Chung, Wen‐Hung et al.

Source: International Journal of Dermatology. Feb2026, p1. 11p. 4 Illustrations.

Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia.

Authors: Sinclair, Rodney Eisman, Samantha Lee, Carol M. Y. et al.

Source: Australasian Journal of Dermatology. Aug2024, Vol. 65 Issue 5, p451-461. 11p.

Pericardial Disorders Occurring during Open Label Study of 3747 Patients Treated with Systemic Minoxidil.

Authors: Sinclair, Rodney¹ (AUTHOR) rodney.sinclair@sinclairdermatology.com.au

Source: International Journal of Trichology. Mar/Apr2025, Vol. 17 Issue 2, p165-167. 3p.

Mucocutaneous alterations and complications in amphetamine abusers: a narrative review.

Authors: Balali-Mood, Mahdi Sinclair, Rodney D. Darchini-Maragheh, Emadodin et al.

Source: Cutaneous & Ocular Toxicology. Dec2023, Vol. 42 Issue 4, p219-231. 13p.

Topical application of a novel anti‐interleukin‐17A antibody fragment penetrates psoriatic skin: Results of a randomised, double‐blind, placebo‐controlled Phase Ib study.

Authors: Sinclair, Rodney Sharifeh, Sammy Thackwray, Susan et al.

Source: Experimental Dermatology. Sep2023, Vol. 32 Issue 9, p1538-1545. 8p.

Upadacitinib treatment in patients with moderate to severe atopic dermatitis: A retrospective single‐centre Australian review of 14 patients post phase 3 clinical trial.

Authors: Bennett, Michaela Sinclair, Rodney D. Eisman, Samantha

Source: Australasian Journal of Dermatology. Feb2023, Vol. 64 Issue 1, p146-150. 5p. 2 Charts.

Painful bilateral gynaecomastia secondary to topical finasteride.

Authors: Thomas, Meryl Sinclair, Rodney

Source: Australasian Journal of Dermatology. Feb2025, Vol. 66 Issue 1, p40-41. 2p.

Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al

Authors: Sinclair, Rodney Mesinkovska, Natasha Mitra, Debanjali et al.

Source: American Journal of Clinical Dermatology. Jan2025, Vol. 26 Issue 1, p109-119. 11p.

Treatment of dissecting cellulitis of the scalp with Tildrakizumab.

Authors: Awad, Andrew Sinclair, Rodney

Source: Australasian Journal of Dermatology. Aug2022, Vol. 63 Issue 3, p404-406. 3p. 1 Color Photograph.

Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata.

Authors: King, Brett McMichael, Amy Sinclair, Rodney et al.

Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3793-3803. 11p.

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial.

Authors: King, Brett Zhang, Xingqi Harcha, Walter Gubelin et al.

Source: Lancet. May2023, Vol. 401 Issue 10387, p1518-1529. 12p.

Subjects: Pfizer Inc., Alopecia areata, Adults, Teenagers, Baldness, African Americans, Kinase inhibitors

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.

Authors: Kimball, Alexa B Jemec, Gregor B E Alavi, Afsaneh et al.

Source: Lancet. Mar2023, Vol. 401 Issue 10378, p747-761. 15p.

Subjects: Hidradenitis suppurativa, Clinical trials, Sunshine, Investigational therapies

Regrowth of hair in congenital triangular alopecia induced by sublingual minoxidil.

Authors: Clarysse, Karlijn L. J. Sinclair, Rodney

Source: Australasian Journal of Dermatology. Feb2023, Vol. 64 Issue 1, p153-154. 2p. 1 Color Photograph.

Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation.

Authors: Cranwell, William C Sinclair, Rodney

Source: Australasian Journal of Dermatology. Aug2017, Vol. 58 Issue 3, pe94-e96. 3p. 4 Color Photographs.

Hidradenitis suppurativa responding to treatment with infliximab.

Authors: Lasocki, Anita Sinclair, Rodney Foley, Peter et al.

Source: Australasian Journal of Dermatology. Aug2010, Vol. 51 Issue 3, p186-190. 5p. 4 Color Photographs, 5 Charts, 1 Graph.

Chronic telogen effluvium is due to a reduction in the variance of anagen duration.

Authors: Gilmore, Stephen Sinclair, Rodney

Source: Australasian Journal of Dermatology. Aug2010, Vol. 51 Issue 3, p163-167. 5p. 1 Color Photograph, 3 Graphs.